Rank #1306LRMR

Larimar Therapeutics, Inc.

$3.11

5.42% (Daily)

Market Cap

$266.19M

Revenue

$N/A

Rank by MCap

#1306

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Carole S. Ben-Maimon M.D.

Headquarters

Bala Cynwyd, PA

Employees

About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.